The High Expression of p53 Is Predictive of Poor Survival Rather TP53 Mutation in Esophageal Squamous Cell Carcinoma

Figure 1

Flow chart of patient selection. Patients who had TP53 mutations by sequencing (a) and p53 protein expression by IHC (b) were included on the basis of clinical and histopathological characteristics and survival status. the TP53 mutation analysis was included in 316 patients. ^# the p53 protein expression analysis was included in 276 patients.

(a)

(b)